Project Details
Description
A Dose-Ranging Efficacy Study of Subcutaneous Administration of Sun-101 in Male & femail C57BL/6 Mice in a Cerulein induced model of chronic pancreatitis
| Status | Finished |
|---|---|
| Effective start/end date | 6/3/14 → 3/31/16 |
Funding
- SUN BIOPHARMA, INC.
Fingerprint
Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.